Lentigen is focused on the development of novel biotherapeutics for the treatment of serious diseases with unmet need. Lentigen also has several indications in development. These include a treatment for Chronic Lymphocytic Leukemia, Glioblastoma, Melanoma and Hemophilia A. Vaccine preclinical programs target Pandemic and Seasonal Influenza and HIV/AIDS. Protein therapeutics include cost efficient production of Erythropoietin and Factor VIII.